A novel study examines the relationship between acne vulgaris and irritable bowel syndrome.
An evaluation of the safety and efficacy of a novel tazarotene topical for acne finds a possible new treatment option.
Expanding recommendations for less frequent laboratory monitoring of patients with acne ≥35 years old prescribed isotretinoin without baseline laboratory abnormalities is now supported.
The use of probiotics as an adjunct therapy may help in the management of acne vulgaris.
As patients with acne often have psychological comorbidities a multidisciplinary approach may yield optimal treatment.
Researchers assessed the incidence of isotretinoin-triggered axial spondyloarthropathy in acne vulgaris patients based on clinical features and MRI findings and examined clinical and radiologic outcomes after drug withdrawal.
Chemical peels of more than 1 acid are just as effective as monotherapy for reducing acne lesions and increasing skin hydration — and produce fewer adverse events.
Acne patients receiving isotretinoin may not need continued testing when experiencing low-grade liver enzyme abnormalities, as most mild elevations do not worsen.
A review of the unique transition-related medical and aesthetic dermatologic needs of patients undergoing transition.